ID

42996

Description

Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) See http://clinicaltrials.gov/ct2/show/record/NCT00661609

Lien

http://clinicaltrials.gov/ct2/show/record/NCT00661609

Mots-clés

  1. 18/11/2011 18/11/2011 -
  2. 26/03/2014 26/03/2014 - Martin Dugas
  3. 17/09/2021 17/09/2021 -
Téléchargé le

17 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility DRKS00004052 NCT00661609 Bladder Cancer

Eligibility Advanced Bladder Cancer NCT00661609

Inclusion criteria
Description

Inclusion criteria

Alias
UMLS CUI-1
C1512693
Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra)
Description

Urothelial Neoplasm

Type de données

boolean

Alias
UMLS CUI-1
C1519840
Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
Description

Stage IV

Type de données

boolean

Alias
UMLS CUI-1
C0441772
Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting
Description

Prior chemotherapy

Type de données

boolean

Alias
UMLS CUI-1
C1514457
Ambulatory and capable of all selfcare more than 50% of waking hours
Description

General status

Type de données

boolean

Alias
UMLS CUI-1
C0947124
Exclusion criteria
Description

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication, 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
Description

Prior treatment

Type de données

boolean

Alias
UMLS CUI-1
C1514463
Inadequate bone marrow reserve
Description

Inadequate bone marrow reserve

Type de données

boolean

Alias
UMLS CUI-1
CL406855
Inadequate liver function in the presence of liver metastases
Description

Liver Dysfunction

Type de données

boolean

Alias
UMLS CUI-1
C0086565
Impaired renal function
Description

Impaired renal function

Type de données

boolean

Alias
UMLS CUI-1
C1565489

Similar models

Eligibility Advanced Bladder Cancer NCT00661609

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI-1)
Urothelial Neoplasm
Item
Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra)
boolean
C1519840 (UMLS CUI-1)
Stage IV
Item
Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
boolean
C0441772 (UMLS CUI-1)
Prior chemotherapy
Item
Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting
boolean
C1514457 (UMLS CUI-1)
General status
Item
Ambulatory and capable of all selfcare more than 50% of waking hours
boolean
C0947124 (UMLS CUI-1)
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Prior treatment
Item
Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication, 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
boolean
C1514463 (UMLS CUI-1)
Inadequate bone marrow reserve
Item
Inadequate bone marrow reserve
boolean
CL406855 (UMLS CUI-1)
Liver Dysfunction
Item
Inadequate liver function in the presence of liver metastases
boolean
C0086565 (UMLS CUI-1)
Impaired renal function
Item
Impaired renal function
boolean
C1565489 (UMLS CUI-1)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial